Pluri Inc PLUR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:12 PM EDT
1.04quote price arrow down-0.02 (-1.89%)
Volume
31,892
52 week range
0.94 - 3.30
Loading...
  • Open1.05
  • Day High1.07
  • Day Low1.04
  • Prev Close1.06
  • 52 Week High3.30
  • 52 Week High Date08/16/21
  • 52 Week Low0.94
  • 52 Week Low Date07/27/22

Key Stats

  • Market Cap33.64M
  • Shares Out32.35M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.78
  • YTD % Change-28.77

KEY STATS

  • Open1.05
  • Day High1.07
  • Day Low1.04
  • Prev Close1.06
  • 52 Week High3.30
  • 52 Week High Date08/16/21
  • 52 Week Low0.94
  • 52 Week Low Date07/27/22
  • Market Cap33.64M
  • Shares Out32.35M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta1.78
  • YTD % Change-28.77

RATIOS/PROFITABILITY

  • EPS (TTM)-1.47
  • P/E (TTM)-0.71
  • Fwd P/E (NTM)-0.92
  • EBITDA (TTM)-46.047M
  • ROE (TTM)-88.22%
  • Revenue (TTM)230,000.00
  • Gross Margin (TTM)0.00%
  • Net Margin (TTM)-20,024.79%
  • Debt To Equity (MRQ)60.18%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pluri Inc

There is no recent news for this security.

Profile

MORE
Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products...
Zalman Aberman
Chairman of the Board
Yaky Yanay
President, Chief Executive Officer, Director
Chen Franco-Yehuda
Chief Financial Officer, Treasurer, Secretary
Address
MATAM Advanced Technology Park
Building #5
Haifa
3508409
Israel

Top Peers

SYMBOLLASTCHG%CHG
INAB
IN8BIO, Inc.
1.86+0.02+0.81%
APLT
Applied Therapeutics Inc
1.34UNCHUNCH
VINC
Vincerx Pharma Inc
1.63+0.05+3.16%
CLBS
Caladrius Biosciences Inc
0.55+0.0128+2.38%
CRBP
Corbus Pharmaceuticals Holdings Inc
0.26+0.0033+1.29%